Ca2+ influx and platelet membrane glycoproteins

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Platelet activation is critical for hemostasis and thrombosis.
• Calcium signaling plays a pivotal role in platelet function.
• The GPIIb/IIIa complex mediates fibrinogen binding and platelet aggregation.

Purpose of the Study:

• To elucidate the sources and regulation of intracellular calcium increase during platelet activation.
• To investigate the role of the GPIIb/IIIa complex and cytoskeletal reorganization in thrombin-induced calcium signaling.
• To explore the potential of targeting calcium influx for antiplatelet therapy.

Main Methods:

• Aequorin luminescence assay to measure intracellular calcium levels.
• Stimulation of platelets with thrombin, collagen, and TPA.
• Inhibition studies using monoclonal antibody TM83, GRGDSP peptide, dihydrocytochalasin B, and ticlopidine.
• Analysis of calcium influx from external medium versus mobilization from storage sites.

Main Results:

• Thrombin stimulation induced two peaks of aequorin luminescence, reflecting both external calcium influx and internal calcium release.
• Inhibition of fibrinogen binding (TM83, GRGDSP) and cytoskeletal reorganization (dihydrocytochalasin B) abolished the second calcium peak.
• Collagen also induced a similar calcium response, while TPA did not.
• Ticlopidine effectively inhibited calcium influx via the GPIIb/IIIa complex.

Conclusions:

• The second calcium peak during thrombin-induced platelet activation is primarily due to external calcium influx, mediated by the GPIIb/IIIa complex.
• Fibrinogen binding to GPIIb/IIIa triggers cytoskeletal changes, leading to secondary calcium influx.
• Targeting GPIIb/IIIa-mediated calcium influx, as with ticlopidine, represents a promising strategy for antiplatelet therapy and preventing thrombus formation.